DMU-212
CAS No. 134029-62-2
DMU-212 ( —— )
产品货号. M28078 CAS No. 134029-62-2
DMU-212 是白藜芦醇的甲基化形式,具有抗有丝分裂、抗增殖和抗氧化活性。 DMU-212 通过激活 ERK1/2 蛋白并促进细胞凋亡来诱导有丝分裂停滞。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥278 | 有现货 |
|
| 5MG | ¥487 | 有现货 |
|
| 10MG | ¥749 | 有现货 |
|
| 25MG | ¥1479 | 有现货 |
|
| 50MG | ¥2539 | 有现货 |
|
| 100MG | ¥3591 | 有现货 |
|
| 500MG | ¥7641 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥432 | 有现货 |
|
生物学信息
-
产品名称DMU-212
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述DMU-212 是白藜芦醇的甲基化形式,具有抗有丝分裂、抗增殖和抗氧化活性。 DMU-212 通过激活 ERK1/2 蛋白并促进细胞凋亡来诱导有丝分裂停滞。
-
产品描述DMU-212, a methylated form of Resveratrol, shows antimitotic, antiproliferative, and antioxidant activities. DMU-212 induces mitotic arrest through the activation of ERK1/2 protein and the promotion of apoptosis.(In Vitro):DMU-212 (0.3125-40 μM) inhibited the cellular proliferation of human melanoma cells at submicromolar or micromolar concentrations (IC50=0.5 μM, 0.5 μM, 1.25 μM, and 1.25 μM for A375, Bro, MeWo, and M5 human melanoma cells, respectively.).(In Vivo):In SCID female mice, DMU-212 (50 mg/kg; i.g.) inhibited tumor growth and lowered tumor burden.
-
体外实验Cell Proliferation Assay Cell Line:A375 cells, MeWo cells, M5 cells, Bro cells Concentration:0.3125 μM, 0,625 μM, 1.25 μM, 2.5 μM, 5 μM, 10 μM, 20 μM, 40 μM Incubation Time:96 hours Result:Inhibited the cellular proliferation of human melanoma cells at submicromolar or micromolar concentrations (IC50=0.5 μM for A375 and Bro and IC50= 1.25 μM for MeWo and M5 cells).Cell Cycle Analysis Cell Line:A375 cells Concentration:20 μM, 30 μM, 50 μM Incubation Time:24 hoursResult:Caused a marked increase in the levels of p21, p53 and cyclin B1 proteins with a concomitant decrease in the levels of cyclin A2.Western Blot Analysis Cell Line:A375 cells Concentration:20 μM, 30 μM, 50 μM Incubation Time:24 hours Result:Significant upregulated Bax, caspase 3 and caspase 9 protein levels, while decreased the levels of the anti-apoptotic protein Bcl-2.Apoptosis Analysis Cell Line:A375 cells Concentration:10 μM, 20 μM Incubation Time:24 hours, 36 hoursResult:Induced apoptosis.
-
体内实验Animal Model:6-weeks-old SCID female mice (20-24 g), with ovarian cancer xenografts Dosage:50 mg/kg Administration:Oral gavage, three times a week, for 14 days Result:Lowered tumor burden.
-
同义词——
-
通路Apoptosis
-
靶点Apoptosis
-
受体Tubulin polymerization
-
研究领域——
-
适应症——
化学信息
-
CAS Number134029-62-2
-
分子量300.35
-
分子式C18H20O4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 20 mg/mL (66.59 mM)
-
SMILESCOC1=CC=C(/C=C/C2=CC(OC)=C(OC)C(OC)=C2)C=C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Schneider Y, et al. Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization. Int J Cancer. 2003 Nov 1;107(2):189-96.
产品手册
关联产品
-
Targapremir-210
Targapremir-210 (TGP-210) 是一种有效的、选择性的 miR-210 (miRNA-210, microRNA-210) 抑制剂。 Targapremir-210 以高亲和力抑制 pre-miR-210 的加工 (Kd~200 nM)。Targapremir-210 是一种点击化学试剂。它含有 Azide 基团,可以和含有 Alkyne 基团的分子发生铜催化的叠氮-炔环加成反应(CuAAc)。还可以和含有 DBCO 或 BCN 基团的分子发生菌株促进的炔-叠氮环加成反应 (SPAAC)。
-
SMIP004
SMIP004 是一种 SKP2 E3 连接酶抑制剂。 SMIP004 是人类前列腺癌细胞的癌细胞选择性凋亡诱导剂。
-
BTT-3033
BTT-3033 是一种具有口服活性的构象选择性的 α2β1 (EC50: 130 nM) 抑制剂,可与 α2I domain 结合。BTT-3033 抑制血小板与 collagen Ⅰ 结合和细胞增殖,并诱导细胞凋亡 (apoptosis)。BTT-3033 可用于前列腺癌、炎症和心血管疾病的研究。
021-51111890
购物车()
sales@molnova.cn

